You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
This year's Nobel Prize in Physiology or Medicine is awarded to three researchers for their discovery of the hepatitis C virus, Reuters reports.
BIO has asked the Department of Health and Human Services to publish the criteria it developed for the emergency authorization of a coronavirus vaccine, the New York Times reports.
New Zealand's Stuff reports on the pressure felt by Institute of Environmental Science and Research scientists as they sequence SARS-CoV-2 samples.
In PLOS this week: no enrichment of rare variants among Parkinson's disease patients in associated genes, circulating tumor DNA helps guide metastatic breast cancer patient management, and more.
According to the Associated Press, the COVAX initiative may be disrupted by wealthier nations by seeking their own vaccine agreements.
A new survey in Stem Cell Reports finds the majority of Americans say they could accept human-animal chimera embryos.
The New York Times reports that two firms developing rapid, antigen-based saliva tests for SARS-CoV-2 have shifted to shallow nose swabs.
In Science this week: somatic mutation heterogeneity among human bladder samples, and more.
Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.
The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.
About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.
In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.
The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.
The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.
Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.
In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.
The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.
Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.
Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.
In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.
The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.
UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.
President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.
In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.
Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.
The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.